Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New bladder testing device under scrutiny in 180-Patient study

NCT ID NCT06336304

Diagnosis Sponsor: Laborie Medical Technologies Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 01, 2026 · Updated 2 times

Summary

This study is testing the NXT Urodynamics System, a device used to measure how well the bladder stores and releases urine. Researchers want to confirm it is safe and works correctly in people with bladder problems like incontinence or overactive bladder. About 180 adults who need a bladder function test will take part. The main goal is to see if the device measures all needed information without causing serious side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

163 people

The number who actually took part.

Started

Jun 2024

Finished

Jun 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Male, Female and Pediatric subjects who have been medically indicated for UDS testing.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients medically indicated for urodynamic study * Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements Exclusion Criteria: * Patients or legally authorized representative with cognitive or psychiatric condition that interferes with or precludes direct and accurate communication regarding the study, giving informed consent or ability to complete the patient questionnaire * Patients with confirmed active bladder infections (not including patients with asymptotic bacteria) * Pregnant women * Patients with recent (less than 2 weeks) pelvic floor surgery * Requires use of suprapubic catheter

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Urinary bladder, neurogenic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

overactive bladder Urinary Bladder, Neurogenic Urinary Incontinence Urinary Incontinence, Urge urinary tract obstruction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Urinary bladder, neurogenic Urinary bladder, overactive Urinary incontinence Urinary incontinence, urge Urinary obstruction

Contacts and locations

Locations

  • Chesapeake Urology Hanover

    Hanover, Maryland, 21076, United States

  • Chesapeake Urology Owing Mills

    Owing Mills, Maryland, 21117, United States

  • Nationwide Children's Hospital

    Columbus, Ohio, 43205, United States

  • Ohio State University

    Columbus, Ohio, 43212, United States

  • University of Virginia

    Charlottesville, Virginia, 22903, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.